
US Exempts Speciality Drugs From Tariffs For India, 19 Other Countries Ahead Of Pharma Duty
The story in brief
The US announced zero per cent tariff exemptions for speciality drugs and associated ingredients used to treat rare medical conditions imported from India and 19 other countries. The exemptions, part of Trump’s April proclamation under Section 232, took effect on July 31 for some companies and will apply to others from September 29.